MAPT and Alzheimer disease: After 2 weeks of treatment, we detected progressive AD-like neuropathology, with an increase of Aβ aggregate production and of tau hyperphosphorylation, and a selective alteration of N-methyl-D-aspartic acid receptor subunit composition in the postsynaptic compartment of mouse brain.